Correction: TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach. [PDF]
Cheraghi-Shavi T +3 more
europepmc +1 more source
Oxygen vacancy-engineered bimetallic nanozymes for disrupting electron transport chain and synergistic multi-enzyme activity to reverse oxaliplatin resistance in colorectal cancer. [PDF]
Zhong D +10 more
europepmc +1 more source
Ferroptosis-related oxaliplatin resistance in multiple cancers: Potential roles and therapeutic Implications. [PDF]
Zhong S +4 more
europepmc +1 more source
Geniposide reverses oxaliplatin resistance in colorectal cancer via suppression of PI3K/AKT pathway
Siyuan Chen, Aijun Chen
openalex +1 more source
Cancer-Associated Fibroblasts Enhance Oxaliplatin Resistance in Colorectal Cancer Cells via Paracrine IL-6: An In Vitro Study. [PDF]
Wang J, Lu Y, Wang Z, Wei P.
europepmc +1 more source
Exploring the therapeutic potential of "Zhi-Zhen" formula for oxaliplatin resistance in colorectal cancer: an integrated study combining UPLC-QTOF-MS/MS, bioinformatics, network pharmacology, and experimental validation. [PDF]
Li Y +6 more
europepmc +1 more source
Gfi-1 modulates HMGB1-Mediated autophagy to overcome oxaliplatin resistance in colorectal cancer. [PDF]
Liu W +6 more
europepmc +1 more source
RETRACTION: Circular RNA circFBXO11 Modulates Hepatocellular Carcinoma Progress and Oxaliplatin Resistance Through miR-605/FOXO3/ABCB1 Axis. [PDF]
europepmc +1 more source

